United Efforts: Successful Signing Ceremony of Executive She Joining New-Line Bio as Shareholder
As an innovative leader in bacteriophage biological applications, Shandong New-Line Biotechnology Co., Ltd. (New-Line Bio) continues to achieve decisive milestones across technological research, industrial development, and enterprise biosecurity.
Driving Green Biosecurity & Antibiotic-Reduction
With global and domestic policies strictly limiting the non-therapeutic use of veterinary antibiotics, intensive farming enterprises require dependable, non-resistant biological solutions. New-Line Bio addresses this demand through our proprietary "Three Libraries, One Platform, and One System" architecture, providing customized lytic bacteriophage cocktails tailored to farm-specific pathogen pressures.
Industry experts, enterprise partners, and clients consistently commend New-Line Bio's dedication to high-throughput discovery, rigorous clinical validation, and sustainable farming value creation. Moving forward, New-Line Bio remains committed to working alongside industry partners to build a shared green future for animal health and global food safety.